Solara Active Pharma Sciences Limited

Web: solara.co.in NSE: SOLARA BSE: 541540 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

524 13(-2%)

Volume

40L as on 15, May

Open

659

High

725

Low

659

536

VWAP

560

52 Week High

734

52 Week Low

422

Viand Research Rating

Quality Score

62/100

Growth Score

61/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

2,501

No. of Shares

3.62

P/E

-7.25

P/B

3.56

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

-49.14

ROCE

Profit Growth

Listing Date

27-Jun-18

Promoter Holding

42%

FII Holding

11.59%

DII Holding

3.75%

Price Chart

Price Performance

1 Week10%

1 Month18%

3 Months16%

6 Months14%

1 Year14%

YTD14%

Moving Average

5 Day SMA525

10 Day SMA520

20 Day SMA504

30 Day SMA496

50 Day SMA477

61 Day SMA477

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	537	513	525	545
Resistance 2	525	512	517	529
Resistance 1	516	510	512	525
Pivot Point	504	508	504	508
Support 1	496	506	496	504
Support 2	483	504	491	487
Support 3	475	502	483	483

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(0.01) 42.00%	(0.01) 42.00%	(0.01) 42.01%	(4.11) 42.01%	(0.71) 37.94%	(0.01) 37.23%	(0.01) 37.27%	(6.81) 37.27%	(0.01) 30.49%	(-6.71) 30.49%	(-2.11) 37.19%	(-1.71) 39.31%	(0.61) 40.98%	(0.01) 40.41%	(0.01) 40.41%	(0.71) 40.40%	(0.21) 39.71%	(-1.61) 39.51%	(0.01) 41.07%
FIIs	(-0.41) 11.59%	(-1.61) 11.98%	(-0.71) 13.58%	(-0.41) 14.25%	(0.01) 14.63%	(0.41) 14.67%	(0.31) 14.25%	(-1.81) 14.00%	(-0.81) 15.80%	(-1.21) 16.62%	(-0.91) 17.86%	(-0.61) 18.71%	(0.01) 19.30%	(0.81) 19.26%	(0.51) 18.47%	(-1.51) 17.93%	(1.31) 19.42%	(0.91) 18.15%	(0.01) 17.28%
DIIs	(0.11) 3.75%	(1.01) 3.64%	(0.11) 2.69%	(0.01) 2.62%	(-0.61) 2.61%	(-0.21) 3.19%	(0.51) 3.37%	(-0.11) 2.83%	(1.21) 2.97%	(0.01) 1.75%	(0.01) 1.79%	(-1.01) 1.75%	(-0.31) 2.75%	(0.01) 3.01%	(-0.11) 2.97%	(-0.51) 3.10%	(-1.81) 3.64%	(-0.61) 5.40%	(0.01) 6.05%
Public	42.66%	42.37%	41.71%	41.10%	44.82%	44.92%	45.11%	45.89%	50.73%	51.14%	43.16%	40.22%	36.95%	37.32%	38.16%	38.57%	37.22%	36.94%	35.60%
No. of Shareholders	70,400	71,890	72,479	74,334	75,791	83,148	71,882	77,170	73,912	72,918	74,473	75,417	76,325	79,149	83,319	82,710	77,228	73,000	65,449

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	387.29	349	313.54	319.15	273.01	300.31	346.95	363.49	299.43	211.94	425.24	352.31	380.62	395	338	330	360.82	100.34	401.61	406
Sales Growth % (YoY)	41.9%	16.2%	-9.6%	-12.2%	-8.8%	41.7%	-18.4%	3.2%	-21.3%	-46.3%	25.7%	6.7%	5.5%	293.4%	-15.8%	-18.6%	-18.8%	-76.5%	1%	16.4%
Sales Growth % (QoQ)	11%	11.3%	-1.8%	16.9%	-9.1%	-13.4%	-4.6%	21.4%	41.3%	-50.2%	20.7%	-7.4%	-3.6%	16.9%	2.4%	-8.5%	259.6%	-75%	-1.1%	-
Expenses	329.63	311.66	278.81	262.13	227.64	242.63	285.64	321.57	289.67	373.63	387.61	333.19	331.85	350	311	318	347.29	197.18	329.75	314
Operating Profit	57.66	37.34	34.73	57.02	45.37	57.68	61.31	41.92	9.76	-161.69	37.63	19.12	48.77	45	28	13	13.53	-96.84	71.86	91
OPM %	14.89	10.7	11.08	17.87	16.62	19.21	17.67	11.53	3.26	-76.29	8.85	5.43	12.81	11	8	4	3.75	-96.51	17.89	23
Other Income	5.55	-6.75	0.49	0.98	5.95	1.49	0.32	0.56	-120.48	-62.32	-4.04	2.04	4.68	7	4	7	4.76	3.21	3.23	5
Interest	27.57	22.45	20.83	23.9	29.12	26.54	28.28	30.87	30.69	25.37	24.44	24.61	21.96	24	22	22	21.47	17.82	17.03	19
Depreciation	26.04	25.57	24.49	23.58	24.3	24.54	25.34	25.07	25.25	25.96	26.21	25.91	26.45	28	29	28	27.82	28.44	28.38	28
Profit before tax	9.6	-17.43	-10.1	10.52	-2.1	8.09	8.01	-13.46	-166.66	-275.34	-17.06	-29.36	5.04	1	-19	-31	-31	-139.89	29.68	50
Tax %	0	0	0	0	0	0	0	0	53.28	0	0	-34.91	25.4	22	-48	-47	-105.84	0	0	0
Net Profit	9.6	-17.43	-10.1	10.52	-2.1	8.09	8.01	-13.46	-255.45	-275.34	-17.06	-19.11	3.76	0	-10	-16	1.81	-139.89	29.68	50
Net Profit Growth % (QoQ)	155.1%	-72.6%	-196%	601%	-126%	1%	159.5%	94.7%	7.2%	-1514%	10.7%	-608.2%	100%	100%	37.5%	-984%	101.3%	-571.3%	-40.6%	-
Net Profit Growth % (YoY)	557.1%	-315.5%	-226.1%	178.2%	99.2%	102.9%	147%	29.6%	-6893.9%	100%	-70.6%	-19.4%	107.7%	100%	-133.7%	-132%	-	-	-	-
TTM Net Profit	-7.41	-19.11	6.41	24.52	0.539999999999999	-252.81	-536.24	-561.31	-566.96	-307.75	-32.41	-25.35	-22.24	-24.19	-164.08	-124.4	-58.4	-60.21	79.68	0
EPS in Rs	2.65	-4.82	-2.79	2.91	-0.58	2.24	2.22	-3.74	-53.2	-57.36	-3.58	-4.07	0.79	0.09	-2.08	-3.42	0.39	-29.2	6.2	10.47

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Sales	1369	1284	1289	1444	1268	1617	1322	1387	521
Sales Growth %	6.6%	-0.4%	-10.7%	13.8%	-21.6%	22.3%	-4.7%	166.2%	-
Expenses	1182	1077	1384	1309	1188	1231	1062	1174	464
Operating Profit	187	206	-95	134	81	386	260	213	57
OPM %	14	16	-7	9	6	24	20	15	11
Other Income	0	8	-185	22	16	29	27	12	2
Interest	95	115	105	90	75	84	78	82	25
Depreciation	100	99	103	111	112	109	94	83	34
Profit before tax	-7	1	-488	-45	-91	222	115	60	0
Tax %	0	0	16	-50	-36	0	0	1	-70
Net Profit	-7	1	-567	-22	-58	221	115	59	0
Net Profit Growth %	-800%	100.2%	-2477.3%	62.1%	-126.2%	92.2%	94.9%	-	-
EPS in Rs	-2.05	0.15	-118.21	-4.62	-12.11	46.22	32.01	17.3	0
Dividend Payout %	0	0	0	-49	0	11	5	22	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Cash from Operating Activity	153	213	109	156	-242	155	242	166	49
Cash from Investing Activity	-99	-37	-4	-81	-243	-106	-359	-113	-85
Cash from Financing Activity	-54	-180	-106	-113	334	92	97	-23	68
Net Cash Flow	1	-4	0	-38	-151	142	-20	30	31

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018
Equity Capital	45	44	40	40	36	36	36	36	27	26	25
Reserves	1208	1210	1054	1046	898	1464	1489	1553	1059	930	739
Borrowings	687	646	796	840	1012	1013	1037	621	722	538	633
Other Liabilities	393	393	342	364	406	386	383	404	346	466	425
Total Liabilities	2333	2293	2232	2290	2351	2899	2945	2614	2153	1960	1821
Fixed Assets	1238	1232	1193	1231	1268	1364	1356	1382	1397	1218	1086
CWIP	205	230	280	272	256	238	239	88	40	40	71
Investments	5	2	2	2	2	2	0	0	0	0	1
Other Assets	886	829	757	786	825	1295	1350	1144	716	701	663
Total Assets	2333	2293	2232	2290	2351	2899	2945	2614	2153	1960	1821

Delivery

#	Date	492 26% 620	Value (Cr)	Q/T 32	Del 34	Del 11
1	22-Jul	536	25	29	41	10
2	21-Jul	559	6	22	54	3
3	20-Jul	570	4	15	48	2
4	17-Jul	571	8	17	55	4
5	16-Jul	578	4	24	50	2
6	15-Jul	578	5	15	44	2
7	14-Jul	576	9	22	42	4
8	13-Jul	585	16	27	46	7
9	10-Jul	569	48	33	43	21
10	9-Jul	567	20	29	58	12
11	8-Jul	560	21	25	46	10
12	7-Jul	560	5	20	46	2
13	6-Jul	560	8	27	55	5
14	3-Jul	576	10	26	51	5
15	2-Jul	572	12	25	54	7
16	1-Jul	566	8	24	47	4
17	30-Jun	576	10	23	55	5
18	29-Jun	572	10	26	50	5
19	25-Jun	568	12	33	50	6
20	24-Jun	572	15	29	43	6
21	23-Jun	579	16	30	35	6
22	22-Jun	587	11	31	46	5
23	19-Jun	563	7	31	49	4
24	18-Jun	568	9	28	58	6
25	17-Jun	581	7	28	49	4
26	16-Jun	589	12	26	42	5
27	15-Jun	601	14	26	36	5
28	12-Jun	609	40	31	26	10
29	11-Jun	581	59	29	18	11
30	10-Jun	573	20	22	29	6
31	9-Jun	580	152	44	13	20
32	8-Jun	525	7	23	30	2
33	5-Jun	535	5	22	43	2
34	4-Jun	543	7	22	39	3
35	3-Jun	539	4	15	46	2
36	2-Jun	543	6	20	42	2
37	1-Jun	547	20	24	29	6
38	29-May	533	10	25	38	4
39	27-May	546	7	30	45	3
40	26-May	558	5	28	52	3
41	25-May	554	9	26	44	4
42	22-May	548	9	23	46	4
43	21-May	564	10	30	47	5
44	20-May	574	22	24	29	7
45	19-May	583	17	23	36	6
46	18-May	561	26	21	29	8
47	15-May	580	231	49	9	21
48	14-May	508	4	19	37	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	2,502c	65c	2.51
22-Jul	2,566c	100c	3.76
21-Jul	2,666c	67c	2.44
17-Jul	2,733c	16c	0.57
16-Jul	2,749c	2c	0.09
15-Jul	2,751c	13c	0.47
14-Jul	2,738c	71c	2.53
13-Jul	2,809c	18c	0.66
10-Jul	2,791c	104c	3.89
09-Jul	2,686c	14c	0.53
08-Jul	2,672c	10c	0.36
07-Jul	2,662c	17c	0.65
06-Jul	2,680c	78c	2.81
02-Jul	2,757c	9c	0.31
30-Jun	2,749c	2c	0.07
29-Jun	2,747c	28c	1.02
26-Jun	2,719c	6c	0.20
25-Jun	2,714c	20c	0.74
24-Jun	2,734c	17c	0.61
23-Jun	2,751c	59c	2.09
22-Jun	2,809c	114c	4.21
19-Jun	2,696c	14c	0.53
18-Jun	2,710c	71c	2.56
17-Jun	2,781c	29c	1.03
16-Jun	2,810c	43c	1.51
15-Jun	2,853c	76c	2.59
12-Jun	2,929c	47c	1.64
11-Jun	2,882c	175c	6.45
10-Jun	2,707c	0	0

Stock Checklist

Price is below from 52 week high low average: 35%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 8 fund scheme(s) across 3 fund house(s) as of Jul26 · Total value ₹55 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Aditya Birla Sun Life Mutual Fund	4	0.10%	-	55.4
Bandhan Mutual Fund	2	0.08%	-	0
Motilal Oswal Mutual Fund	2	0.01%	-	0

Solara Active Pharma Sciences Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements